Sandoz Group AG
SDZ
Classement en actions
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Prix de l'action
$95.99
Capitalisation boursière
$41.53B
Changement (1 jour)
0.79%
Changement (1 an)
58.61%
Pays
CH
Échange Sandoz Group AG (SDZ)
Catégorie
Healthcare
EPS pour Sandoz Group AG (SDZ)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Sandoz Group AG, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Sandoz Group AG de 2020 à 2026
EPS à la fin de chaque année
| Année | EPS | Changez |
|---|---|---|
| 2025 | $2.12 | 0.00% |
| 2024 | 0.00 | -100.00% |
| 2023 | $0.18 | -90.86% |
| 2022 | $1.97 | 2.60% |
| 2021 | $1.92 | 102.11% |
| 2020 | $0.95 | 0.00% |
EPS pour des entreprises ou concurrents similaires
| Entreprise | EPS | Différence d’EPS | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
